• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

Lingotto

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Optalysys raises £23m in a Series A extension led by Northern Gritstone to challenge conventional computing with photonic chipsOptalysys raises £23m in a Series A extension led by Northern Gritstone to challenge conventional computing with photonic chips
    Optalysys
    22 Jan 2026

    Optalysys raises £23m in a Series A extension led by Northern Gritstone to challenge conventional computing with photonic chips

    Optalysys builds photonic computing chips that process and move data using light, aiming to overcome power and performance limits of electronic computing for AI, encryption and next-generation cloud workloads.

    Viewture raises Series A round led by Bolt Ventures to provide upfront funds to global creatorsViewture raises Series A round led by Bolt Ventures to provide upfront funds to global creators
    Viewture
    5 Nov 2025

    Viewture raises Series A round led by Bolt Ventures to provide upfront funds to global creators

    Viewture offers upfront financing to online creators in exchange for a share of future advertising revenue, providing non-dilutive capital to support growth without losing ownership.

Lingotto
    • Deep Tech
    • Media & Entertainment
  • 2(12 months)
  • lingotto.com
  • Update Information

More venture news

  • Origin raises a £22m Series A+ led by Notion Capital for enterprise benefits intelligence platform
    Origin
    25 Mar 2026

    Origin raises a £22m Series A+ led by Notion Capital for enterprise benefits intelligence platform

    ExtensionHR
  • Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
    Brainomix
    24 Feb 2026

    Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis

    ExtensionHealth
  • Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy
    Centauri Therapeutics
    24 Feb 2026

    Centauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy

    ExtensionLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn